Jun 13, 2007
By:
Beth Herskovits
Biotech takes issue with move to limit reimbursement.
|
Jun 6, 2007
By:
Beth Herskovits
Restasis goes against the grain of Rx-to-OTC switching.
|
Jun 6, 2007
By:
Beth Herskovits
Drug makers find it hard to recoup development costs, report finds.
|
Jun 6, 2007
By:
Beth Herskovits
Active Care Network and biotech partners aim to increase patient compliance.
|
May 23, 2007
By:
Beth Herskovits
Schwarz's Neupro is company's first new chemical entity launched in US.
|
May 23, 2007
By:
Beth Herskovits
Beneficiaries don't switch back to brands after trying generics.
|
May 23, 2007
By:
Beth Herskovits
Provenge setback not deterring others in the field.
|
May 16, 2007
By:
Beth Herskovits
'Very hostile' FDA panel recommends tighter prescribing guidelines.
|
May 16, 2007
By:
Beth Herskovits
High settlement could suggest frustration with pharma's marketing tactics.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
